Bone Graft Substitutes: Current Concepts and Future Expectations.


Journal

The Journal of hand surgery
ISSN: 1531-6564
Titre abrégé: J Hand Surg Am
Pays: United States
ID NLM: 7609631

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 04 06 2018
revised: 25 09 2018
accepted: 23 10 2018
pubmed: 2 2 2019
medline: 5 3 2020
entrez: 2 2 2019
Statut: ppublish

Résumé

Owing to its osteoinductive and osteoconductive properties and the presence of osteogenic cells, freshly harvested autologous bone graft is the gold standard for skeletal reconstruction where there is inadequate native bone. Whereas these characteristics are difficult to replicate, engineered, commercially available bone graft substitutes aim to achieve a comparable osseoregenerative profile. This work furnishes the reader with an understanding of the predominant classes of bone graft substitutes available for reconstruction of upper extremity bone defects following trauma or oncological surgery. We review bone graft substitutes with respect to their mechanisms of action, their advantages and disadvantages, and their indications and contraindications. We provide examples of bone graft substitutes in clinical use and outline comparative costs. We also describe the future directions for this specific aspect of reconstructive surgery with a focus on the role of bioactive glass.

Identifiants

pubmed: 30704784
pii: S0363-5023(18)30766-4
doi: 10.1016/j.jhsa.2018.10.032
pii:
doi:

Substances chimiques

13-93 bioactive glass 0
Bone Morphogenetic Proteins 0
Bone Substitutes 0
Calcium Phosphates 0
Polymethyl Methacrylate 9011-14-7
Durapatite 91D9GV0Z28
tricalcium phosphate K4C08XP666
Calcium Sulfate WAT0DDB505

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

497-505.e2

Informations de copyright

Copyright © 2019 American Society for Surgery of the Hand. Published by Elsevier Inc. All rights reserved.

Auteurs

David C Lobb (DC)

Department of Plastic and Maxillofacial Surgery, University of Virginia, Charlottesville, VA. Electronic address: dcl3s@virgina.edu.

Brent R DeGeorge (BR)

Department of Plastic and Maxillofacial Surgery, University of Virginia, Charlottesville, VA.

A Bobby Chhabra (AB)

Department of Orthopaedic Surgery, University of Virginia, Charlottesville, VA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH